⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

James RussellMD

Medical Oncology · Philadelphia, PA 19104

NPI: 1942243225

Share:

31

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingElevated cost per beneficiary

Risk indicators are statistical patterns, not allegations. Learn more

110

Total Claims

$310K

Drug Cost

18

Beneficiaries

$17K

Cost/Patient

Risk Score Breakdown 31/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+3
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 3,372 Medical Oncology providers

+552%

Opioid rate vs peers

38.2% vs 5.9% avg

+41%

Cost per patient vs peers

$17K vs $12K avg

+96%

Brand preference vs peers

26.4% vs 13.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 552% above the average for Medical Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

38.2%

Opioid Rate

42

Opioid Claims

$5,590

Opioid Cost

Long-Acting Rate

This provider's opioid prescribing rate of 38.2% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

74% generic

Brand: 29 claims · $278K

Generic: 81 claims · $32K

Patient Profile

44

Avg Age

Female

5.35

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About